Abstract
AbstractViruses possessing class I fusion proteins require proteolytic activation by host cell proteases to mediate fusion with the host cell membrane. The mammalian SPINT2 gene encodes a protease inhibitor that targets trypsin-like serine proteases. Here we show the protease inhibitor, SPINT2, restricts cleavage-activation efficiently for a range of influenza viruses and for human metapneumovirus (HMPV). SPINT2 treatment resulted in the cleavage and fusion inhibition of full-length influenza A/CA/04/09 (H1N1) HA, A/Aichi/68 (H3N2) HA, A/Shanghai/2/2013 (H7N9) HA and HMPV F when activated by trypsin, recombinant matriptase or KLK5. We also demonstrate that SPINT2 was able to reduce viral growth of influenza A/CA/04/09 H1N1 and A/X31 H3N2 in cell culture by inhibiting matriptase or TMPRSS2. Moreover, inhibition efficacy did not differ whether SPINT2 was added at the time of infection or 24 hours post-infection. Our data suggest that the SPINT2 inhibitor has a strong potential to serve as a novel broad-spectrum antiviral.
Publisher
Cold Spring Harbor Laboratory
Reference64 articles.
1. World Health Organization. 2014. Global Epidemiological Surveillance Standards for Influenza. https://www.who.int/influenza/resources/documents/WHO_Epidemiological_Influenza_Surveillance_Standards_2014.pdf.
2. Fouchier RAM , Guan Y . 2013. Ecology and evolution of influenza viruses in wild and domestic birds. Textb Influ 173–189.
3. Yen H , Webster RG. 2009. Pandemic Influenza as a Current Threat, p. 3–24. In Current Topics in Microbiology and Immunology.
4. World Health Organization. 2017. WHO | Human infection with avian influenza A(H7N9) virus – China. https://www.who.int/csr/don/26-october-2017-ah7n9-china/en/ http://www.
5. World Health Organization. 2018. Influenza fact sheet. https://www.who.int/news-room/fact-sheets/detail/i https://www.who.int/news-room/fact-sheets/detail/i.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献